Ceftriaxone: Clinical Trials

48 trials of Ceftriaxone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 7 unknown, 4 not yet recruiting, 4 recruiting. 48 Phase 3, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 348Completed 30, Unknown 7, Not yet recruiting 4, Recruiting 4, Terminated 3
Phase 27Completed 4, Unknown 2, Terminated 1

Follow Ceftriaxone: new trials by email Literature Review of Ceftriaxone trials Research Report on Ceftriaxone

Trials (filtered) newest first · largest first

All 48 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis
Piperacillin/Tazobactam, Ceftriaxone + Metronidazole - Appendicitis Perforated, Appendectomy, Laparoscopic
Phase 3Not yet recruitingMcMaster Children's Hospital1802027-04-012026-10-09
AUTOP 2: Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth
Vaginal flora abnormalities screening and quantification using molecular biology technique, Azithromycin, Ceftriaxone - Bacterial Vaginosis, Vaginal Dysbiosis
Phase 3Not yet recruitingAssistance Publique Hopitaux De Marseille17942026-10-012026-08-27
Efficacy of Temocillin Compared to Standard of Care in the Treatment of Neisseria Gonorrhoeae Infections
Temocillin (NEGABAN®) 2 g intravenous with lidocaine (3ml), Rectal swab for ESBL-E and microbiota (Eswab), Temocillin (NEGABAN®) 2 g intramuscular single dose with lidocaine (3ml) - Neisseria Gonorrhoeae (Ng) Infections
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris3602026-09-012026-06-22
A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor
Combination of antibiotics, Emergency cerclage, Vaginal progesterone - Previable Labour With Intact Membranes
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris3502026-09-012026-05-01
500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection
ceftriaxone 500-mg, ceftriaxone 1000-mg - Gonorrhea Infection
Phase 3RecruitingNational Taiwan University Hospital4002026-07-012026-07-17
PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury
Ceftriaxone 2g diluted in >200ml 0.9%sodium chloride, Placebo comparator - no ceftriaxone - All-cause Mortality, Quality of Life
Phase 3RecruitingThe George Institute33002025-10-302026-08-28
Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients
ROCEPHIN, metronidazole, RIFADIN, IZILOX, placebo combination therapy, Lymecyclin and corresponding placebos of the experimental arm - Hidradenitis Suppurativa
Phase 3RecruitingInstitut Pasteur922025-05-222025-07-09
Prophylactic Antibiotic in Subtalar Fusion Surgery
Ceftriaxone 2000 mg - Surgical Site Infection
Phase 2 / Phase 3UnknownAssiut University1022024-09-012024-07-30
Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria
Ceftriaxone (Rocephin®), Levofloxacin - Urinary Tract Infection (Diagnosis)
Phase 2 / Phase 3CompletedAin Shams University1402024-07-012025-11-17
Clearance of Asymptomatic Pharyngeal Carriage of Neisseria Gonorrhoeae With or Without Ceftriaxone Treatment: Randomized Non-inferiority Study
Absence of antibiotic treatment, Ceftriaxone - Neisseria Gonorrhoeae Infection, Asymptomatic Pharyngeal Carriage
Phase 3UnknownAssistance Publique - Hôpitaux de Paris2542023-09-012023-08-02
Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma
Ceftriaxone Sodium - Antibiotic Prophylaxis
Phase 3UnknownNadeem Iqbal1582022-11-262022-12-16
Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition
Ceftriaxone Sodium, Ampicillin, Gentamicin - HIV-1-infection, Malnutrition, Child
Phase 2 / Phase 3UnknownMakerere University3002021-06-142021-09-30
Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
Kunamin®, Favipiravir, Enoxaparin - COVID-19 Respiratory Infection, FLU
Phase 3CompletedRAAS Nutritionals, LLC712021-05-292022-06-14
Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD
Beta-Lactams, Fluoroquinolone - COPD Exacerbation Acute
Phase 2 / Phase 3CompletedHaiphong University of Medicine and Pharmacy1702020-01-012021-05-10
Zoliflodacin in Uncomplicated Gonorrhoea
zoliflodacin, ceftriaxone, azithromycin - Gonorrhea
Phase 3CompletedGlobal Antibiotics Research and Development Partnership10112019-11-062025-10-08
A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea
Gepotidacin, Ceftriaxone, Azithromycin - Gonorrhea
Phase 3CompletedGlaxoSmithKline6282019-10-212024-05-30
A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia
Benzyl penicillin, Gentamicin Sulfate, Ceftriaxone - Pneumonia
Phase 3CompletedUniversity of Oxford43922019-08-192024-07-08
New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea
Ertapenem 1000 MG, Fosfomycin Oral Suspension, Gentamicin Sulfate, Injectable - Gonorrhea
Phase 3CompletedPublic Health Service of Amsterdam3462017-09-182021-08-06
First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition
Ceftriaxone, Benzyl penicillin, Metronidazole - Malnutrition Severe, Antibiotic Resistance
Phase 3UnknownUniversity of Oxford20002017-09-042020-05-19
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
SDD Oral Paste, SDD Gastric Suspension, Intravenous Antibiotic - Critical Illness, Sepsis
Phase 3CompletedThe George Institute200102017-05-012023-08-14

Showing 20 of 48. Sign in to see all of them.

Conditions studied

Gonorrhea (8)  ·  Community-Acquired Pneumonia (7)  ·  Pneumonia (7)  ·  Infections (4)  ·  Bacterial Infections (3)  ·  Pneumonia, Bacterial (3)  ·  Sepsis (3)  ·  Urinary Tract Infections (3)  ·  Disease (2)  ·  Haemophilus Infections (2)  ·  Influenza, Human (2)  ·  Intraabdominal Infections (2)  ·  Lyme Disease (2)  ·  Premature Birth (2)  ·  Sexually Transmitted Diseases (2)

Sponsors

Assistance Publique - Hôpitaux de Paris (6)  ·  Bayer (3)  ·  Forest Laboratories (3)  ·  Melinta Therapeutics, Inc. (3)  ·  Makerere University (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Pfizer (2)  ·  The George Institute (2)  ·  University of Oxford (2)  ·  Aga Khan University (1)  ·  Ain Shams University (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Assiut University (1)  ·  Basilea Pharmaceutica (1)  ·  GlaxoSmithKline (1)

Countries

United States (12)  ·  France (10)  ·  Spain (6)  ·  Australia (5)  ·  Germany (5)  ·  Hungary (5)  ·  India (5)  ·  United Kingdom (5)  ·  Argentina (4)  ·  Bulgaria (4)  ·  Canada (4)  ·  Netherlands (4)  ·  Poland (4)  ·  Belgium (3)  ·  Mexico (3)

Top investigators

A.K. Deb (1)  ·  Ahmad Zia Ud Din (1)  ·  Ambrose Agweyu, PhD (1)  ·  Andrew Udy, Prof (1)  ·  Anita KM Zaidi, MBBS, SM (1)  ·  Anthony Delaney, Prof (1)  ·  Anthony Gordon, MD FRCA (1)  ·  Antonella Toffolo, Dr (1)  ·  Brian Cuthbertson, MD FRCA (1)  ·  Colin McArthur, Dr (1)  ·  Cordelia M Katureebe, MBCHB (1)  ·  David Melnick (1)  ·  Deepak Dewan (1)  ·  Derek Angus, Prof (1)

Results publications

PMID 26702925, PMID 30597021, PMID 34922058, PMID 21482570, PMID 23357290, PMID 25487791, PMID 17611232, PMID 18419482, PMID 18567539, PMID 18762516, PMID 21129208, PMID 21482566, PMID 21482568, PMID 22230331, PMID 23352693, PMID 23613806, PMID 24207137, PMID 25151205, PMID 25297012, PMID 25442806, PMID 25539586, PMID 25631195, PMID 26229155, PMID 27093162, PMID 28864675, PMID 30380060, PMID 30808293, PMID 30936104, PMID 30985632, PMID 31044546, PMID 31196813, PMID 31433059, PMID 32267771, PMID 32665381, PMID 32876697, PMID 33394942, PMID 33509275, PMID 33631065, PMID 33960817, PMID 34155899, PMID 34251506, PMID 34351721, PMID 34351722, PMID 34473343, PMID 34606578, PMID 35065063, PMID 35237053, PMID 35315874, PMID 35813373, PMID 35820778

NIH funding

2023 (3), 2014 (1), 2015 (1), 2018 (1), 2019 (1), 2025 (1), U01NS049640 (1)